Trial Outcomes & Findings for Emergency Department Longitudinal Integrated Care (NCT NCT03699085)

NCT ID: NCT03699085

Last Updated: 2023-06-22

Results Overview

Percentage of subjects who agree to participate in screening survey prior to determining eligibility status. Potential subjects identified by suspected risky substance use history based on EMR review

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

Baseline

Results posted on

2023-06-22

Participant Flow

Baseline survey completed prior to randomization

Participant milestones

Participant milestones
Measure
ED-LINC Intervention Condition
Patients in this arm will receive the ED-LINC intervention. Elements of ED-LINC are based on evidence-based treatments and are central components of collaborative care. ED-LINC will be supported by a novel Emergency Department Information Exchange (EDIE) technology platform that allows for the creation of ED care plans and electronic alerts and will assist in care coordination of this complex population. ED-LINC: ED-LINC will include 1) A brief negotiated interview at the bedside with an emphasis on motivation to link to services 2) Pharmacotherapy including a discussion of opioid safety, take-home naloxone and initiation of buprenorphine from the ED for participants that are interested and eligible; 3) Longitudinal care management which will proceed for 3-months; and 4) Care plan in the Emergency Department Information Exchange (EDIE) system. This will be coupled with a study cell phone and a weekly supervisory case conference which is consistent with collaborative care principles.
Usual Care Condition
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Overall Study
STARTED
20
20
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Emergency Department Longitudinal Integrated Care

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ED-LINC Intervention Condition
n=20 Participants
Patients in this arm will receive the ED-LINC intervention. Elements of ED-LINC are based on evidence-based treatments and are central components of collaborative care. ED-LINC will be supported by a novel Emergency Department Information Exchange (EDIE) technology platform that allows for the creation of ED care plans and electronic alerts and will assist in care coordination of this complex population. ED-LINC: ED-LINC will include 1) A brief negotiated interview at the bedside with an emphasis on motivation to link to services 2) Pharmacotherapy including a discussion of opioid safety, take-home naloxone and initiation of buprenorphine from the ED for participants that are interested and eligible; 3) Longitudinal care management which will proceed for 3-months; and 4) Care plan in the Emergency Department Information Exchange (EDIE) system. This will be coupled with a study cell phone and a weekly supervisory case conference which is consistent with collaborative care principles.
Usual Care Condition
n=20 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
35.5 years
STANDARD_DEVIATION 10.7 • n=5 Participants
39.4 years
STANDARD_DEVIATION 9.3 • n=7 Participants
37.4 years
STANDARD_DEVIATION 10 • n=5 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
10 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
10 Participants
n=7 Participants
22 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
4 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
White
11 Participants
n=5 Participants
12 Participants
n=7 Participants
23 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
4 Participants
n=5 Participants
0 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Region of Enrollment
United States
20 participants
n=5 Participants
20 participants
n=7 Participants
40 participants
n=5 Participants
Heroin Use
19 Participants
n=5 Participants
19 Participants
n=7 Participants
38 Participants
n=5 Participants
Prescription Opioid Misuse
6 Participants
n=5 Participants
2 Participants
n=7 Participants
8 Participants
n=5 Participants
Lifetime Opioid Overdose
10 Participants
n=5 Participants
13 Participants
n=7 Participants
23 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Population: Potential subjects identified by suspected history of risky substance use based on EMR review

Percentage of subjects who agree to participate in screening survey prior to determining eligibility status. Potential subjects identified by suspected risky substance use history based on EMR review

Outcome measures

Outcome measures
Measure
Approached Subjects
n=118 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Refusal Rate
Refused Screening Survey
5 Participants
Refusal Rate
Participated in Screening Survey
113 Participants

PRIMARY outcome

Timeframe: 6 months

The number of participants who completed follow-ups at 6 month time point.

Outcome measures

Outcome measures
Measure
Approached Subjects
n=20 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
n=20 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Follow up Completion Rates
Completed 6 month followup
18 Participants
19 Participants
Follow up Completion Rates
No 6 month followup
2 Participants
1 Participants

PRIMARY outcome

Timeframe: 6 months

Number of participants that received at least 1 ED-LINC element

Outcome measures

Outcome measures
Measure
Approached Subjects
n=20 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
n=20 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
ED-LINC Intervention and Usual Care Process Outcomes
At least 1 ED LINC element received
20 Participants
0 Participants
ED-LINC Intervention and Usual Care Process Outcomes
No ED LINC elements received
0 Participants
20 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Participants were asked to rate the agreeability of the statement "ED LINC seemed fitting and suitable"

Participants randomized to ED-LINC care were asked about the appropriateness of interventional activities.by rating the agreeability of the statement "ED LINC seemed fitting and suitable"

Outcome measures

Outcome measures
Measure
Approached Subjects
n=20 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Implementation Appropriateness
Agreed or Completely Agreed
18 Participants
Implementation Appropriateness
Answered OTHER than Agreed or Completely Agreed
2 Participants

PRIMARY outcome

Timeframe: 6 months

Client Satisfaction Questionnaire (CSQ-8) questions (8-32) will be used to assess satisfaction with ED-LINC, in which greater numbers designate higher satisfaction (32 is maximum or highest satisfaction rating possible)

Outcome measures

Outcome measures
Measure
Approached Subjects
n=20 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
n=20 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
ED-LINC Satisfaction
29 score on a scale
Interval 26.0 to 32.0
30 score on a scale
Interval 26.0 to 32.0

PRIMARY outcome

Timeframe: 6 months

The Patient Assessment of Chronic Illness Care - Coordination (PACIC-C) questions will be asked of all participants, where greater numbers indicate perception was more coordinated (greater number is better). For the scale, scores must be discrete numbers, with a minimum possible value of 5 and maximum possible value of 25.

Outcome measures

Outcome measures
Measure
Approached Subjects
n=18 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
n=19 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Perception of Care Coordination
15 score on a scale
Interval 11.25 to 19.25
13 score on a scale
Interval 9.0 to 15.5

SECONDARY outcome

Timeframe: 6 months

Comparison between control population and intervention population based on substance use measured utilizing a time-line follow back (TLFB) calendar administered by the research assistant to for past 30-day heroin use at TLFB timepoints (Baseline, 1 month, 3 months, 6 months). Table shows the average of unadjusted TLFB days of Heroin Use with 95% Confidence Interval.

Outcome measures

Outcome measures
Measure
Approached Subjects
n=20 Participants
Number of potential subjects who were approached for potential participation
Usual Care Condition
n=20 Participants
Patients in this arm may receive a spectrum of consulting services visits including social work services, psychiatric consultation, inpatient psychiatry consult, rehabilitation psychology consultation, addiction intervention services, pain team consultation services that include MD psychiatric and PhD psychologist providers, spiritual care or other consulting services which shall count as usual care.
Substance Use
Baseline
18.3 unadjusted TLFB days
Standard Error 2.89
16.85 unadjusted TLFB days
Standard Error 2.80
Substance Use
Month 1
11.95 unadjusted TLFB days
Standard Error 2.95
12.85 unadjusted TLFB days
Standard Error 2.93
Substance Use
Month 3
8.9 unadjusted TLFB days
Standard Error 2.88
12.45 unadjusted TLFB days
Standard Error 3.13
Substance Use
Month 6
13.1 unadjusted TLFB days
Standard Error 2.92
9.4 unadjusted TLFB days
Standard Error 3.06

SECONDARY outcome

Timeframe: 6 months

Population: Data was unable to be obtained during the funding period. No data collection of EDIE utilization occurred during this study because team was unable to access EDIE data.

Emergency department (ED) utilization will be assessed using the Emergency Department Information Exchange (EDIE) .

Outcome measures

Outcome data not reported

Adverse Events

ED-LINC Intervention Condition

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care Condition

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lauren Whiteside, Primary Investigator

University of Washington

Phone: 206-744-8464

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place